The post LayerZero Buys Back 50M Tokens in Strategic Move appeared on BitcoinEthereumNews.com. Key Points: LayerZero executed a $120M buyback impacting governance and liquidity. ZRO surged 26% post-announcement. Stargate DAO dissolved, emphasizing governance consolidation. The LayerZero Foundation executed a $120 million buyback of 50 million ZRO tokens from early investors, marking a strategic merger with Stargate Finance, under CEO Bryan Pellegrino’s leadership. The buyback consolidates governance under LayerZero, replaces STG with ZRO for protocol operations, and triggers a notable 26% increase in ZRO’s market price. LayerZero’s $120 Million Buyback Reshapes Governance LayerZero’s strategic decision to acquire 50 million ZRO tokens impacted its governance structure. This decision follows the recent acquisition of Stargate Finance, with CEO Bryan Pellegrino emphasizing the alignment between the two entities. Stargate Finance DAO approved the buyback with a 94.7% majority, absorbing Stargate assets into the LayerZero protocol. Price implications include a 26% increase in the ZRO token value on various trading platforms. This integrates Stargate’s liquidity, marking the phasing out of the STG token. ZRO now presides over all governance and protocol operations, dissolving the Stargate DAO. Market reaction was notable, driven by developer and voter engagement from the Stargate DAO community. While competing protocols advocated for delays, the LayerZero leadership stressed the developmental advantages from the merger. Pelligrino underscored this merger as an opportunity to highlight synergy between LayerZero and Stargate operations. “Add fuel to the fire of Stargate’s development and underline strategic alignment between the two entities,” – Bryan Pellegrino, CEO, LayerZero Labs. Market Impacts and Expert Predictions Post-Buyback Did you know? The $120 million LayerZero buyback marks one of the largest acquisitions involving a DAO, highlighting a significant pivot towards governance integration and technological consolidation. According to CoinMarketCap data, LayerZero (ZRO) stands at $1.91 with a market cap of $472.64 million and shows a 24-hour trading volume increase of 160.53%. ZRO experienced notable price fluctuations, including… The post LayerZero Buys Back 50M Tokens in Strategic Move appeared on BitcoinEthereumNews.com. Key Points: LayerZero executed a $120M buyback impacting governance and liquidity. ZRO surged 26% post-announcement. Stargate DAO dissolved, emphasizing governance consolidation. The LayerZero Foundation executed a $120 million buyback of 50 million ZRO tokens from early investors, marking a strategic merger with Stargate Finance, under CEO Bryan Pellegrino’s leadership. The buyback consolidates governance under LayerZero, replaces STG with ZRO for protocol operations, and triggers a notable 26% increase in ZRO’s market price. LayerZero’s $120 Million Buyback Reshapes Governance LayerZero’s strategic decision to acquire 50 million ZRO tokens impacted its governance structure. This decision follows the recent acquisition of Stargate Finance, with CEO Bryan Pellegrino emphasizing the alignment between the two entities. Stargate Finance DAO approved the buyback with a 94.7% majority, absorbing Stargate assets into the LayerZero protocol. Price implications include a 26% increase in the ZRO token value on various trading platforms. This integrates Stargate’s liquidity, marking the phasing out of the STG token. ZRO now presides over all governance and protocol operations, dissolving the Stargate DAO. Market reaction was notable, driven by developer and voter engagement from the Stargate DAO community. While competing protocols advocated for delays, the LayerZero leadership stressed the developmental advantages from the merger. Pelligrino underscored this merger as an opportunity to highlight synergy between LayerZero and Stargate operations. “Add fuel to the fire of Stargate’s development and underline strategic alignment between the two entities,” – Bryan Pellegrino, CEO, LayerZero Labs. Market Impacts and Expert Predictions Post-Buyback Did you know? The $120 million LayerZero buyback marks one of the largest acquisitions involving a DAO, highlighting a significant pivot towards governance integration and technological consolidation. According to CoinMarketCap data, LayerZero (ZRO) stands at $1.91 with a market cap of $472.64 million and shows a 24-hour trading volume increase of 160.53%. ZRO experienced notable price fluctuations, including…

LayerZero Buys Back 50M Tokens in Strategic Move

Key Points:
  • LayerZero executed a $120M buyback impacting governance and liquidity.
  • ZRO surged 26% post-announcement.
  • Stargate DAO dissolved, emphasizing governance consolidation.

The LayerZero Foundation executed a $120 million buyback of 50 million ZRO tokens from early investors, marking a strategic merger with Stargate Finance, under CEO Bryan Pellegrino’s leadership.

The buyback consolidates governance under LayerZero, replaces STG with ZRO for protocol operations, and triggers a notable 26% increase in ZRO’s market price.

LayerZero’s $120 Million Buyback Reshapes Governance

LayerZero’s strategic decision to acquire 50 million ZRO tokens impacted its governance structure. This decision follows the recent acquisition of Stargate Finance, with CEO Bryan Pellegrino emphasizing the alignment between the two entities. Stargate Finance DAO approved the buyback with a 94.7% majority, absorbing Stargate assets into the LayerZero protocol. Price implications include a 26% increase in the ZRO token value on various trading platforms. This integrates Stargate’s liquidity, marking the phasing out of the STG token. ZRO now presides over all governance and protocol operations, dissolving the Stargate DAO. Market reaction was notable, driven by developer and voter engagement from the Stargate DAO community. While competing protocols advocated for delays, the LayerZero leadership stressed the developmental advantages from the merger. Pelligrino underscored this merger as an opportunity to highlight synergy between LayerZero and Stargate operations.

Market Impacts and Expert Predictions Post-Buyback

Did you know? The $120 million LayerZero buyback marks one of the largest acquisitions involving a DAO, highlighting a significant pivot towards governance integration and technological consolidation.

According to CoinMarketCap data, LayerZero (ZRO) stands at $1.91 with a market cap of $472.64 million and shows a 24-hour trading volume increase of 160.53%. ZRO experienced notable price fluctuations, including a recent 5.31% drop over 24 hours. The fully diluted market cap totals $1.91 billion. Expert analysis from Coincu research highlights potential technological outcomes, suggesting a streamlined cross-chain protocol with strengthened financial positioning following this strategic maneuver. ZRO’s evolving role within LayerZero’s consolidated governance and liquidity might bolster its utility and market positioning.

LayerZero(ZRO), daily chart, screenshot on CoinMarketCap at 16:07 UTC on September 22, 2025. Source: CoinMarketCap

Source: https://coincu.com/news/layerzero-50m-token-buyback/

Market Opportunity
Stargate Finance Logo
Stargate Finance Price(STG)
$0.1876
$0.1876$0.1876
+13.69%
USD
Stargate Finance (STG) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26